Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7580826 | 0.69 | — | — | |
| SCHEMBL3104437 | 0.67 | — | — | |
| SCHEMBL6058725 | 0.67 | — | — | |
| SCHEMBL6058726 | 0.67 | — | — | |
| SCHEMBL1420447 | 0.65 | ALDH1A1 (0.33) | — | |
| SCHEMBL11852700 | 0.65 | — | — | |
| SCHEMBL2641504 | 0.63 | — | — | |
| SCHEMBL4201275 | 0.61 | — | — | |
| SCHEMBL8025324 | 0.61 | — | — | |
| SCHEMBL3101954 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7932326-B2 | Chelating compounds and immobilized tethered chelators | THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2011-04-26 | — | — | US | claimed |
| US-20090261043-A1 | CHELATING COMPOUNDS AND IMMOBILIZED TETHERED CHELATORS | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2009-10-22 | — | — | US | claimed |
| US-5514380-A | Biodegradable hydrogel copolymer as drug delivery matrix | SAM YANG CO., LTD. (KR) | 1996-05-07 | — | — | US | claimed |
| US-4504620-A | ADHESION PROMOTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-03-12 | — | — | US | claimed |
| US-20030144457-A1 | Binders, coatings, inks, adhesives | AKZO NOBEL N.V. (NL) | 2003-07-31 | — | — | US | disclosed |
| WO-2003054060-A1 | HYPERBRANCHED ESTEROXAZOLINE POLYMERS | AKZO NOBEL N.V. (NL) | 2003-07-03 | — | — | WO | disclosed |
| EP-0992854-B1 | Concentrate and aqueous developer for image-wise exposed recording materials | AGFA GEVAERT (BE) | 2003-01-29 | — | — | EP | disclosed |
| EP-0992854-A1 | Concentrate and aqueous developer for image-wise exposed recording materials | Agfa-Gevaert AG (DE) | 2000-04-12 | — | — | EP | disclosed |
| EP-0900786-A1 | New surface active compounds, method for their preparation, and their use | MONSANTO EUROPE S.A./N.V. (BE) | 1999-03-10 | — | — | EP | disclosed |
| US-5514380-A | Biodegradable hydrogel copolymer as drug delivery matrix | SAM YANG CO., LTD. (KR) | 1996-05-07 | — | — | US | disclosed |
| US-5155011-A | Mixture of water, organic solvent, alkali agent, anionic surfactant, alkanoic acid or salt, emulsifier, complexing agent, tris/hydroxyalkyl/aminomethane buffer; stability | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-13 | — | — | US | disclosed |
| US-5155011-A | Mixture of water, organic solvent, alkali agent, anionic surfactant, alkanoic acid or salt, emulsifier, complexing agent, tris/hydroxyalkyl/aminomethane buffer; stability | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-13 | — | — | US | disclosed |
| US-4504620-A | ADHESION PROMOTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-03-12 | — | — | US | disclosed |
| US-4330644-A | Curable tris(hydroxyalkyl) aminomethane-modified epoxy resin composition | SHELL OIL COMPANY (US) | 1982-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090261043-A1 | CHELATING COMPOUNDS AND IMMOBILIZED TETHERED CHELATORS | BTD, SLC30A7, SLC39A7 | MEN1 1842/4885LMNA 3626/4885KMT2A 535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.